Purified antigen fractions of inactivated split virion Influenza A/Indonesia/5/05 (H5N1)
Key facts
| Active substance |
Purified antigen fractions of inactivated split virion Influenza A/Indonesia/5/05 (H5N1)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/79/2009
|
| PIP number |
Purified antigen fractions of inactivated split virion Influenza A/Indonesia/5/05 (H5N1)
|
| Pharmaceutical form(s) |
Emulsion and suspension for emulsion for injection
|
| Condition(s) / indication(s) |
Influenza infection caused by an influenza strain contained in the vaccine or related to a strain contained in the vaccine
|
| Route(s) of administration |
Intramuscular injection
|
| Contact for public enquiries |
GlaxoSmithKline Biologicals S.A. (UK)
E-mail: eu.paediatric-plans@gsk.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|